APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Anti-Infective Medications

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global OTC Anti-Infective Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026197 pages

Choose your research edition.

Industry ResearchOTC Anti-Infective Medications Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Anti-Infective Medications Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal OTC Anti-Infective Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Anti-Infective Medications Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Anti-Infective Medications Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global OTC Anti-Infective Medications market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for OTC Anti-Infective Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OTC Anti-Infective Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Anti-Infective Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for OTC Anti-Infective Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of OTC Anti-Infective Medications include Abbott, Sanofi, Novartis, Merck, Roche, Pfizer, GlaxoSmithKline, Optimer Pharmaceuticals and Novabay Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global OTC Anti-Infective Medications market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OTC Anti-Infective Medications and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OTC Anti-Infective Medications revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the OTC Anti-Infective Medications market size, projected growth trends, production technologies, key applications, and end-use industries.

OTC Anti-Infective Medications Segment by Company

Abbott

Sanofi

Novartis

Merck

Roche

Pfizer

GlaxoSmithKline

Optimer Pharmaceuticals

Novabay Pharmaceuticals

NanoViricides

MerLion Pharma

Bristol-Myers Squibb

Basilea Pharmaceutica

OTC Anti-Infective Medications Segment by Type

Antiseptic

Antiparasitics

Antifungals

OTC Anti-Infective Medications Segment by Application

E-Commerce

Drug Stores

Hospital Pharmacies

OTC Anti-Infective Medications Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Anti-Infective Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Anti-Infective Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Anti-Infective Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of OTC Anti-Infective Medications in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global OTC Anti-Infective Medications industry.

Chapter 3: Detailed analysis of OTC Anti-Infective Medications companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, OTC Anti-Infective Medicationsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global OTC Anti-Infective Medications Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Antiseptic Table 3. Key Players of Antiparasitics Table 4. Key Players of Antifungals Table 4. Global OTC Anti-Infective Medications Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of E-Commerce Table 6. Key Players of Drug Stores Table 7. Key Players of Hospital Pharmacies Table 8. Global OTC Anti-Infective Medications Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global OTC Anti-Infective Medications Market Size by Region (2021-2026) & (US$ Million) Table 10. Global OTC Anti-Infective Medications Market Share by Region (2021-2026) Table 11. Global OTC Anti-Infective Medications Market Size by Region (2027-2032) & (US$ Million) Table 12. Global OTC Anti-Infective Medications Market Share by Region (2027-2032) Table 13. OTC Anti-Infective Medications Industry Trends Table 14. OTC Anti-Infective Medications Industry Drivers Table 15. OTC Anti-Infective Medications Industry Opportunities and Challenges Table 16. OTC Anti-Infective Medications Industry Restraints Table 17. Global OTC Anti-Infective Medications Revenue by Company (US$ Million) & (2021-2026) Table 18. Global OTC Anti-Infective Medications Revenue Market Share by Company (2021-2026) Table 19. Global OTC Anti-Infective Medications Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global OTC Anti-Infective Medications Key Company Head Office and Area Served Table 21. Global OTC Anti-Infective Medications Company, Product Type & Application Table 22. Global OTC Anti-Infective Medications Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global OTC Anti-Infective Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global OTC Anti-Infective Medications Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global OTC Anti-Infective Medications Market Size by Type (2021-2026) & (US$ Million) Table 27. Global OTC Anti-Infective Medications Market Size by Type (2027-2032) & (US$ Million) Table 28. Global OTC Anti-Infective Medications Revenue Market Share by Type (2021-2026) Table 29. Global OTC Anti-Infective Medications Revenue Market Share by Type (2027-2032) Table 30. Global OTC Anti-Infective Medications Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global OTC Anti-Infective Medications Market Size by Application (2021-2026) & (US$ Million) Table 32. Global OTC Anti-Infective Medications Market Size by Application (2027-2032) & (US$ Million) Table 33. Global OTC Anti-Infective Medications Revenue Market Share by Application (2021-2026) Table 34. Global OTC Anti-Infective Medications Revenue Market Share by Application (2027-2032) Table 35. Abbott Company Information Table 36. Abbott Business Overview Table 37. Abbott OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Abbott OTC Anti-Infective Medications Product Portfolio Table 39. Abbott Recent Development Table 40. Sanofi Company Information Table 41. Sanofi Business Overview Table 42. Sanofi OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Sanofi OTC Anti-Infective Medications Product Portfolio Table 44. Sanofi Recent Development Table 45. Novartis Company Information Table 46. Novartis Business Overview Table 47. Novartis OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Novartis OTC Anti-Infective Medications Product Portfolio Table 49. Novartis Recent Development Table 50. Merck Company Information Table 51. Merck Business Overview Table 52. Merck OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Merck OTC Anti-Infective Medications Product Portfolio Table 54. Merck Recent Development Table 55. Roche Company Information Table 56. Roche Business Overview Table 57. Roche OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Roche OTC Anti-Infective Medications Product Portfolio Table 59. Roche Recent Development Table 60. Pfizer Company Information Table 61. Pfizer Business Overview Table 62. Pfizer OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Pfizer OTC Anti-Infective Medications Product Portfolio Table 64. Pfizer Recent Development Table 65. GlaxoSmithKline Company Information Table 66. GlaxoSmithKline Business Overview Table 67. GlaxoSmithKline OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. GlaxoSmithKline OTC Anti-Infective Medications Product Portfolio Table 69. GlaxoSmithKline Recent Development Table 70. Optimer Pharmaceuticals Company Information Table 71. Optimer Pharmaceuticals Business Overview Table 72. Optimer Pharmaceuticals OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Optimer Pharmaceuticals OTC Anti-Infective Medications Product Portfolio Table 74. Optimer Pharmaceuticals Recent Development Table 75. Novabay Pharmaceuticals Company Information Table 76. Novabay Pharmaceuticals Business Overview Table 77. Novabay Pharmaceuticals OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Novabay Pharmaceuticals OTC Anti-Infective Medications Product Portfolio Table 79. Novabay Pharmaceuticals Recent Development Table 80. NanoViricides Company Information Table 81. NanoViricides Business Overview Table 82. NanoViricides OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. NanoViricides OTC Anti-Infective Medications Product Portfolio Table 84. NanoViricides Recent Development Table 85. MerLion Pharma Company Information Table 86. MerLion Pharma Business Overview Table 87. MerLion Pharma OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. MerLion Pharma OTC Anti-Infective Medications Product Portfolio Table 89. MerLion Pharma Recent Development Table 90. Bristol-Myers Squibb Company Information Table 91. Bristol-Myers Squibb Business Overview Table 92. Bristol-Myers Squibb OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Bristol-Myers Squibb OTC Anti-Infective Medications Product Portfolio Table 94. Bristol-Myers Squibb Recent Development Table 95. Basilea Pharmaceutica Company Information Table 96. Basilea Pharmaceutica Business Overview Table 97. Basilea Pharmaceutica OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Basilea Pharmaceutica OTC Anti-Infective Medications Product Portfolio Table 99. Basilea Pharmaceutica Recent Development Table 100. North America OTC Anti-Infective Medications Market Size by Type (2021-2026) & (US$ Million) Table 101. North America OTC Anti-Infective Medications Market Size by Type (2027-2032) & (US$ Million) Table 102. North America OTC Anti-Infective Medications Market Size by Application (2021-2026) & (US$ Million) Table 103. North America OTC Anti-Infective Medications Market Size by Application (2027-2032) & (US$ Million) Table 104. North America OTC Anti-Infective Medications Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America OTC Anti-Infective Medications Market Size by Country (2021-2026) Table 106. North America OTC Anti-Infective Medications Market Size by Country (2027-2032) Table 107. Europe OTC Anti-Infective Medications Market Size by Type (2021-2026) & (US$ Million) Table 108. Europe OTC Anti-Infective Medications Market Size by Type (2027-2032) & (US$ Million) Table 109. Europe OTC Anti-Infective Medications Market Size by Application (2021-2026) & (US$ Million) Table 110. Europe OTC Anti-Infective Medications Market Size by Application (2027-2032) & (US$ Million) Table 111. Europe OTC Anti-Infective Medications Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe OTC Anti-Infective Medications Market Size by Country (2021-2026) Table 113. Europe OTC Anti-Infective Medications Market Size by Country (2027-2032) Table 114. China OTC Anti-Infective Medications Market Size by Type (2021-2026) & (US$ Million) Table 115. China OTC Anti-Infective Medications Market Size by Type (2027-2032) & (US$ Million) Table 116. China OTC Anti-Infective Medications Market Size by Application (2021-2026) & (US$ Million) Table 117. China OTC Anti-Infective Medications Market Size by Application (2027-2032) & (US$ Million) Table 118. Asia OTC Anti-Infective Medications Market Size by Type (2021-2026) & (US$ Million) Table 119. Asia OTC Anti-Infective Medications Market Size by Type (2027-2032) & (US$ Million) Table 120. Asia OTC Anti-Infective Medications Market Size by Application (2021-2026) & (US$ Million) Table 121. Asia OTC Anti-Infective Medications Market Size by Application (2027-2032) & (US$ Million) Table 122. Asia OTC Anti-Infective Medications Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Asia OTC Anti-Infective Medications Market Size by Country (2021-2026) Table 124. Asia OTC Anti-Infective Medications Market Size by Country (2027-2032) Table 125. South America, Middle East & Africa OTC Anti-Infective Medications Market Size by Type (2021-2026) & (US$ Million) Table 126. South America, Middle East & Africa OTC Anti-Infective Medications Market Size by Type (2027-2032) & (US$ Million) Table 127. South America, Middle East & Africa OTC Anti-Infective Medications Market Size by Application (2021-2026) & (US$ Million) Table 128. South America, Middle East & Africa OTC Anti-Infective Medications Market Size by Application (2027-2032) & (US$ Million) Table 129. South America, Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. South America, Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2021-2026) Table 131. South America, Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2027-2032) Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. OTC Anti-Infective Medications Product Image Figure 2. Global OTC Anti-Infective Medications Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global OTC Anti-Infective Medications Market Share by Type: 2025 VS 2032 Figure 4. Antiseptic Image Figure 5. Antiparasitics Image Figure 6. Antifungals Image Figure 7. Global OTC Anti-Infective Medications Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global OTC Anti-Infective Medications Market Share by Application: 2025 VS 2032 Figure 9. E-Commerce Image Figure 10. Drug Stores Image Figure 11. Hospital Pharmacies Image Figure 12. Global OTC Anti-Infective Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 14. Global OTC Anti-Infective Medications Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global OTC Anti-Infective Medications Market Share by Players in 2025 Figure 17. Global Top 5 and 10 OTC Anti-Infective Medications Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global OTC Anti-Infective Medications Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global OTC Anti-Infective Medications Revenue Market Share by Type (2021-2032) Figure 21. Global OTC Anti-Infective Medications Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global OTC Anti-Infective Medications Revenue Market Share by Application (2021-2032) Figure 23. North America OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 24. North America OTC Anti-Infective Medications Market Share by Type (2021-2032) Figure 25. North America OTC Anti-Infective Medications Market Share by Application (2021-2032) Figure 26. North America OTC Anti-Infective Medications Market Share by Country (2021-2032) Figure 27. United States OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 28. Canada OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 29. Mexico OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 30. Europe OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 31. Europe OTC Anti-Infective Medications Market Share by Type (2021-2032) Figure 32. Europe OTC Anti-Infective Medications Market Share by Application (2021-2032) Figure 33. Europe OTC Anti-Infective Medications Market Share by Country (2021-2032) Figure 34. Germany OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 35. France OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 36. U.K. OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 37. Italy OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 38. Russia OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 40. China OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 41. China OTC Anti-Infective Medications Market Share by Type (2021-2032) Figure 42. China OTC Anti-Infective Medications Market Share by Application (2021-2032) Figure 43. Asia OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 44. Asia OTC Anti-Infective Medications Market Share by Type (2021-2032) Figure 45. Asia OTC Anti-Infective Medications Market Share by Application (2021-2032) Figure 46. Asia OTC Anti-Infective Medications Market Share by Country (2021-2032) Figure 47. Japan OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 48. South Korea OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 51. India OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 52. Australia OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa OTC Anti-Infective Medications Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa OTC Anti-Infective Medications Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa OTC Anti-Infective Medications Market Share by Country (2021-2032) Figure 57. Brazil OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 58. South Africa OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 60. Turkey OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 61. Argentina OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 62. UAE OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 63. Egypt OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 64. Chile OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Antiseptic
  • Antiparasitics
  • Antifungals
Applications
  • E-Commerce
  • Drug Stores
  • Hospital Pharmacies
Companies covered
  • Abbott
  • Sanofi
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • Optimer Pharmaceuticals
  • Novabay Pharmaceuticals
  • NanoViricides
  • MerLion Pharma
  • Bristol-Myers Squibb
  • Basilea Pharmaceutica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global OTC Anti-Infective Medications Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Antiseptic
  5. 1.2.3 Antiparasitics
  6. 1.2.4 Antifungals
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global OTC Anti-Infective Medications Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 E-Commerce
  10. 1.3.3 Drug Stores
  11. 1.3.4 Hospital Pharmacies
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global OTC Anti-Infective Medications Growth Trends by Region
  14. 1.5.1 Global OTC Anti-Infective Medications Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 OTC Anti-Infective Medications Market Size by Region (2021-2026)
  16. 1.5.3 OTC Anti-Infective Medications Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global OTC Anti-Infective Medications Market Dynamics
  1. 2.1 OTC Anti-Infective Medications Industry Trends
  2. 2.2 OTC Anti-Infective Medications Industry Drivers
  3. 2.3 OTC Anti-Infective Medications Industry Opportunities and Challenges
  4. 2.4 OTC Anti-Infective Medications Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global OTC Anti-Infective Medications Revenue by Company (2021-2026)
  2. 3.2 Global OTC Anti-Infective Medications Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global OTC Anti-Infective Medications Key Company Head office and Area Served
  4. 3.4 Global OTC Anti-Infective Medications Company, Product Type & Application
  5. 3.5 Global OTC Anti-Infective Medications Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global OTC Anti-Infective Medications Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 OTC Anti-Infective Medications Players Market Share by Revenue in 2025
  9. 3.6.3 2025 OTC Anti-Infective Medications Tier 1, Tier 2, and Tier 3
4 OTC Anti-Infective Medications Market by Type
  1. 4.1 Global OTC Anti-Infective Medications Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global OTC Anti-Infective Medications Market Size by Type (2021-2032)
  3. 4.3 Global OTC Anti-Infective Medications Market Size Share by Type (2021-2032)
5 OTC Anti-Infective Medications Market by Application
  1. 5.1 Global OTC Anti-Infective Medications Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global OTC Anti-Infective Medications Market Size by Application (2021-2032)
  3. 5.3 Global OTC Anti-Infective Medications Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Abbott OTC Anti-Infective Medications Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Sanofi OTC Anti-Infective Medications Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Novartis OTC Anti-Infective Medications Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Merck OTC Anti-Infective Medications Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Roche OTC Anti-Infective Medications Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Pfizer OTC Anti-Infective Medications Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 GlaxoSmithKline OTC Anti-Infective Medications Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Optimer Pharmaceuticals
  44. 6.8.1 Optimer Pharmaceuticals Company Information
  45. 6.8.2 Optimer Pharmaceuticals Business Overview
  46. 6.8.3 Optimer Pharmaceuticals OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Optimer Pharmaceuticals OTC Anti-Infective Medications Product Portfolio
  48. 6.8.5 Optimer Pharmaceuticals Recent Developments
  49. 6.9 Novabay Pharmaceuticals
  50. 6.9.1 Novabay Pharmaceuticals Company Information
  51. 6.9.2 Novabay Pharmaceuticals Business Overview
  52. 6.9.3 Novabay Pharmaceuticals OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Novabay Pharmaceuticals OTC Anti-Infective Medications Product Portfolio
  54. 6.9.5 Novabay Pharmaceuticals Recent Developments
  55. 6.10 NanoViricides
  56. 6.10.1 NanoViricides Company Information
  57. 6.10.2 NanoViricides Business Overview
  58. 6.10.3 NanoViricides OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 NanoViricides OTC Anti-Infective Medications Product Portfolio
  60. 6.10.5 NanoViricides Recent Developments
  61. 6.11 MerLion Pharma
  62. 6.11.1 MerLion Pharma Company Information
  63. 6.11.2 MerLion Pharma Business Overview
  64. 6.11.3 MerLion Pharma OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 MerLion Pharma OTC Anti-Infective Medications Product Portfolio
  66. 6.11.5 MerLion Pharma Recent Developments
  67. 6.12 Bristol-Myers Squibb
  68. 6.12.1 Bristol-Myers Squibb Company Information
  69. 6.12.2 Bristol-Myers Squibb Business Overview
  70. 6.12.3 Bristol-Myers Squibb OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Bristol-Myers Squibb OTC Anti-Infective Medications Product Portfolio
  72. 6.12.5 Bristol-Myers Squibb Recent Developments
  73. 6.13 Basilea Pharmaceutica
  74. 6.13.1 Basilea Pharmaceutica Company Information
  75. 6.13.2 Basilea Pharmaceutica Business Overview
  76. 6.13.3 Basilea Pharmaceutica OTC Anti-Infective Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Basilea Pharmaceutica OTC Anti-Infective Medications Product Portfolio
  78. 6.13.5 Basilea Pharmaceutica Recent Developments
7 North America
  1. 7.1 North America OTC Anti-Infective Medications Market Size (2021-2032)
  2. 7.2 North America OTC Anti-Infective Medications Market Size by Type
  3. 7.2.1 North America OTC Anti-Infective Medications Market Size by Type (2021-2026)
  4. 7.2.2 North America OTC Anti-Infective Medications Market Size by Type (2027-2032)
  5. 7.2.3 North America OTC Anti-Infective Medications Market Share by Type (2021-2032)
  6. 7.3 North America OTC Anti-Infective Medications Market Size by Application
  7. 7.3.1 North America OTC Anti-Infective Medications Market Size by Application (2021-2026)
  8. 7.3.2 North America OTC Anti-Infective Medications Market Size by Application (2027-2032)
  9. 7.3.3 North America OTC Anti-Infective Medications Market Share by Application (2021-2032)
  10. 7.4 North America OTC Anti-Infective Medications Market Size by Country
  11. 7.4.1 North America OTC Anti-Infective Medications Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America OTC Anti-Infective Medications Market Size by Country (2021-2026)
  13. 7.4.3 North America OTC Anti-Infective Medications Market Size by Country (2027-2032)
  14. 7.4.4 North America OTC Anti-Infective Medications Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe OTC Anti-Infective Medications Market Size (2021-2032)
  2. 8.2 Europe OTC Anti-Infective Medications Market Size by Type
  3. 8.2.1 Europe OTC Anti-Infective Medications Market Size by Type (2021-2026)
  4. 8.2.2 Europe OTC Anti-Infective Medications Market Size by Type (2027-2032)
  5. 8.2.3 Europe OTC Anti-Infective Medications Market Share by Type (2021-2032)
  6. 8.3 Europe OTC Anti-Infective Medications Market Size by Application
  7. 8.3.1 Europe OTC Anti-Infective Medications Market Size by Application (2021-2026)
  8. 8.3.2 Europe OTC Anti-Infective Medications Market Size by Application (2027-2032)
  9. 8.3.3 Europe OTC Anti-Infective Medications Market Share by Application (2021-2032)
  10. 8.4 Europe OTC Anti-Infective Medications Market Size by Country
  11. 8.4.1 Europe OTC Anti-Infective Medications Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe OTC Anti-Infective Medications Market Size by Country (2021-2026)
  13. 8.4.3 Europe OTC Anti-Infective Medications Market Size by Country (2027-2032)
  14. 8.4.4 Europe OTC Anti-Infective Medications Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China OTC Anti-Infective Medications Market Size (2021-2032)
  2. 9.2 China OTC Anti-Infective Medications Market Size by Type
  3. 9.2.1 China OTC Anti-Infective Medications Market Size by Type (2021-2026)
  4. 9.2.2 China OTC Anti-Infective Medications Market Size by Type (2027-2032)
  5. 9.2.3 China OTC Anti-Infective Medications Market Share by Type (2021-2032)
  6. 9.3 China OTC Anti-Infective Medications Market Size by Application
  7. 9.3.1 China OTC Anti-Infective Medications Market Size by Application (2021-2026)
  8. 9.3.2 China OTC Anti-Infective Medications Market Size by Application (2027-2032)
  9. 9.3.3 China OTC Anti-Infective Medications Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia OTC Anti-Infective Medications Market Size (2021-2032)
  2. 10.2 Asia OTC Anti-Infective Medications Market Size by Type
  3. 10.2.1 Asia OTC Anti-Infective Medications Market Size by Type (2021-2026)
  4. 10.2.2 Asia OTC Anti-Infective Medications Market Size by Type (2027-2032)
  5. 10.2.3 Asia OTC Anti-Infective Medications Market Share by Type (2021-2032)
  6. 10.3 Asia OTC Anti-Infective Medications Market Size by Application
  7. 10.3.1 Asia OTC Anti-Infective Medications Market Size by Application (2021-2026)
  8. 10.3.2 Asia OTC Anti-Infective Medications Market Size by Application (2027-2032)
  9. 10.3.3 Asia OTC Anti-Infective Medications Market Share by Application (2021-2032)
  10. 10.4 Asia OTC Anti-Infective Medications Market Size by Country
  11. 10.4.1 Asia OTC Anti-Infective Medications Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia OTC Anti-Infective Medications Market Size by Country (2021-2026)
  13. 10.4.3 Asia OTC Anti-Infective Medications Market Size by Country (2027-2032)
  14. 10.4.4 Asia OTC Anti-Infective Medications Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa OTC Anti-Infective Medications Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa OTC Anti-Infective Medications Market Size by Type
  3. 11.2.1 South America, Middle East & Africa OTC Anti-Infective Medications Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa OTC Anti-Infective Medications Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa OTC Anti-Infective Medications Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa OTC Anti-Infective Medications Market Size by Application
  7. 11.3.1 South America, Middle East & Africa OTC Anti-Infective Medications Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa OTC Anti-Infective Medications Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa OTC Anti-Infective Medications Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa OTC Anti-Infective Medications Market Size by Country
  11. 11.4.1 South America, Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa OTC Anti-Infective Medications Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst